Glaxo Handing Over Record $3B To Settle FCA Claims
GlaxoSmithKline PLC will plead guilty and pay a record-setting $3 billion penalty to resolve whistleblower charges that it promoted drugs for unapproved uses, omitted safety data about its medicines and violated...To view the full article, register now.
Already a subscriber? Click here to view full article